Cimetidine as an adjuvant treatment in colorectal cancer. A double-blind, randomized pilot study.


PURPOSE To evaluate the influence of a H2 receptor antagonist (cimetidine) on survival in patients with colorectal carcinoma, a randomized, controlled pilot study was performed in three university hospitals in Copenhagen, Denmark. METHODS A total of 192 patients, who had undergone a resection or an exploratory operation for adenocarcinoma of the colon or… (More)


  • Presentations referencing similar topics